Skip to main content
. 2020 Feb 15;12(2):219–227. doi: 10.4251/wjgo.v12.i2.219

Figure 2.

Figure 2

Discriminant analysis results of colorectal cancer and healthy control group, malignant disease group and benign disease group. A: ROC curve of the discriminant analysis model of the colorectal cancer and healthy control group, respectively; B: ROC curve of the discriminant analysis model of the colorectal cancer and healthy control group.